Abstract
Prospective, multi-country, observational study of patients with endogenous Cushing's syndrome exposed to Ketoconazole (using the existing European Registry on Cushing's Syndrome (ERCUSYN)), to assess drug use, safety and effectiveness
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have